TGFB1 and neoplasm: Conversely, the Nox1/4 inhibitor GKT137831 can dose-dependently inhibit ROS generation, block TGF-β1-induced fibroblast activation, matrix migration, and CAF phenotypic transformation, thus negating the tumor-promoting effect of its conditioned medium on PCa cells.